Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
5
Bearish filings
53
Named actors
10
Disclosed $ (bull / bear)
size unknown / $4.0M + 3 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-01 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Daniel Lorrain | filed notice to sell | $56K | SEC ↗ |
| 2026-09-08 | CEO and President Stengone Carmine N. | sold | $41K | SEC ↗ |
| 2026-09-08 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) CARMINE STENGONE | filed notice to sell | $42K | SEC ↗ |
| 2026-09-01 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Daniel Lorrain | filed notice to sell | $155K | SEC ↗ |
| 2026-08-03 | CEO and President Stengone Carmine N. | sold | $40K |
33 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-03 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Daniel Lorrain | filed notice to sell | $147K | SEC ↗ |
| 2026-08-03 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) CARMINE STENGONE | filed notice to sell | $39K | SEC ↗ |
| 2026-07-27 | 5%+ holder (13G) BlackRock, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-07-09 | Chief Scientific Officer Lorrain Daniel S. | sold | $400 | SEC ↗ |
| 2026-07-08 | CEO and President Stengone Carmine N. | sold | $40K | SEC ↗ |
| 2026-07-08 | Chief Scientific Officer Lorrain Daniel S. | sold | $16K | SEC ↗ |
| 2026-07-08 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) CARMINE STENGONE | filed notice to sell | $36K | SEC ↗ |
| 2026-07-01 | Chief Scientific Officer Lorrain Daniel S. | sold | $41K | SEC ↗ |
| 2026-07-01 | Chief Scientific Officer Lorrain Daniel S. | sold | $92K | SEC ↗ |
| 2026-07-01 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Daniel Lorrain | filed notice to sell | $156K | SEC ↗ |
| 2026-06-30 | CEO and President Stengone Carmine N. | sold | $160K | SEC ↗ |
| 2026-06-30 | CMO & Head of Development Watkins Tim | sold | $174K | SEC ↗ |
| 2026-06-30 | Chief Scientific Officer Lorrain Daniel S. | sold | $462K | SEC ↗ |
| 2026-06-30 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) TIMOTHY WATKINS | filed notice to sell | $162K | SEC ↗ |
| 2026-06-30 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) CARMINE STENGONE | filed notice to sell | $150K | SEC ↗ |
| 2026-06-30 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Daniel Lorrain | filed notice to sell | $432K | SEC ↗ |
| 2026-06-01 | Chief Scientific Officer Lorrain Daniel S. | sold | $55K | SEC ↗ |
| 2026-06-01 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) DANIEL LORRAIN | filed notice to sell | $56K | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) BALYASNY ASSET MANAGEMENT L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-01 | Chief Scientific Officer Lorrain Daniel S. | sold | $51K | SEC ↗ |